
Cardiol Therapeutics (CRDL)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Cardiol Therapeutics (CRDL) Stock
Start investing in Cardiol Therapeutics (CRDL)
About Cardiol Therapeutics (CRDL)
Market cap | $120.67M |
Today's volume | 177.05K |
Revenue (TTM) | — |
Avg. daily volume | 196.93K |
EBITDA (TTM) | -$28.8M |
Open | $1.42 |
Price / earnings ratio | -4.23x |
Today's range | $1.38 - $1.5 |
Debt / equity | 0.86x |
52 week range | $0.77 - $2.63 |
5 year debt / equity | 0.4x |
Beta (LTM) | 1.39x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 3.26x |
Ex-dividend date | — |
Next earnings | Aug 11, 2025 |
Dividend payable date | — |
Cardiol Therapeutics Stock Rating
Cardiol Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy CRDL stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in CRDL stock
Navigate to the Explore page. Then, type CRDL into the search bar. When you see CRDL stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased CRDL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Cardiol Therapeutics Stock Earnings
The value each CRDL share was expected to gain vs. the value that each CRDL share actually gained.
Cardiol Therapeutics (CRDL) reported Q4 2024 earnings per share (EPS) of -$0.07, beating estimates of -$0.08 by 12.50%. In the same quarter last year, Cardiol Therapeutics's earnings per share (EPS) was -$0.09. Cardiol Therapeutics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of $0.